
Sanofi has continued to make progress in the development of Icaria (isatuximab), with the company announcing that the therapy met …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

